Patents by Inventor Christophe Romeuf

Christophe Romeuf has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF AN ANTIBODY DIRECTED AGAINST A MEMBRANE PROTEIN
    Publication number: 20130315820
    Abstract: An antibody directed against the BDCA-2 protein for the prevention or the treatment of the pathologies involving activation of the plasmacytoid dendritic cells.
    Type: Application
    Filed: December 12, 2011
    Publication date: November 28, 2013
    Applicant: LFB BIOTECHNOLOGIES
    Inventors: Nathalie Fournier, Christophe Romeuf
  • Novel lgG3 Antibodies for Stimulating Phagocytosis
    Publication number: 20070218052
    Abstract: The invention relates to human or humanised, chimeric, monoclonal, class IgG3 antibodies produced in a cell line of rat myeloma, especially line YB2/0. Said antibodies have a strong phagocytosis activity and can be administered for the treatment of cancers and infections.
    Type: Application
    Filed: October 18, 2004
    Publication date: September 20, 2007
    Applicant: Labopratoire Francais du Fractionnement et des Biotechnologies
    Inventors: Christophe Romeuf, Sylvie Jorieux, Dominique Bourel, Philippe Klein, Nicolas Bihoreau
  • Anti-Rhesus D monoclonal antibodies
    Publication number: 20070009522
    Abstract: The invention concerns a method for obtaining and selecting monoclonal antibodies by an ADDC-type test, said antibodies capable of activating type III Fcy receptors and having a particular glycan structure.
    Type: Application
    Filed: September 8, 2006
    Publication date: January 11, 2007
    Inventors: Roland Beliard, Dominique Bourel, Arnaud Glacet, Christophe Romeuf, Nicolas Bihoreau, Emmanuel Nony